JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve the unaudited ....
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed BSE that its Board of Directors will meet on July 30, 2025 to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The intimation is filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. No financial details, estimates, or guidance have been provided in this filing. Signed by Sandeep Phadnis, Vice President – Secretarial & Company Secretary.
This is a routine regulatory intimation with no direct impact on the stock. Investors should watch for the actual Q1 results on July 30, 2025 for performance insights.